Literature DB >> 27032642

Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations.

Casey L Swanson1, Jamie N Bakkum-Gamez2.   

Abstract

OPINION STATEMENT: In women at increased risk of developing ovarian cancer, risk-reducing salpingo-oophorectomy is the only intervention that has been shown to decrease mortality from ovarian cancer and is the standard of care for risk reduction. Prophylactic salpingectomy with delayed oophorectomy should be considered in high-risk premenopausal women in the setting of a clinical trial.

Entities:  

Keywords:  BRCA; Fimbriectomy; Hereditary breast and ovarian cancer syndrome; Oophorectomy; Ovarian cancer; Salpingectomy

Mesh：

Year:  2016        PMID： 27032642     DOI： 10.1007/s11864-016-0396-2

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN： 1534-6277


  34 in total

1.  ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy.

Authors: 
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

Review 2.  Long-term health consequences of premature or early menopause and considerations for management.

Authors:  S S Faubion; C L Kuhle; L T Shuster; W A Rocca
Journal:  Climacteric       Date:  2015-04-07       Impact factor: 3.005

3.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

4.  Inherited Mutations in Women With Ovarian Carcinoma.

Authors:  Barbara M Norquist; Maria I Harrell; Mark F Brady; Tom Walsh; Ming K Lee; Suleyman Gulsuner; Sarah S Bernards; Silvia Casadei; Qian Yi; Robert A Burger; John K Chan; Susan A Davidson; Robert S Mannel; Paul A DiSilvestro; Heather A Lankes; Nilsa C Ramirez; Mary Claire King; Elizabeth M Swisher; Michael J Birrer
Journal:  JAMA Oncol       Date:  2016-04       Impact factor: 31.777

Review 5.  Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.

Authors:  Laura J Havrilesky; Patricia G Moorman; William J Lowery; Jennifer M Gierisch; Remy R Coeytaux; Rachel Peragallo Urrutia; Michaela Dinan; Amanda J McBroom; Vic Hasselblad; Gillian D Sanders; Evan R Myers
Journal:  Obstet Gynecol       Date:  2013-07       Impact factor: 7.661

6.  A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.

Authors:  Karen H Lu; Steven Skates; Mary A Hernandez; Deepak Bedi; Therese Bevers; Leroy Leeds; Richard Moore; Cornelius Granai; Steven Harris; William Newland; Olasunkanmi Adeyinka; Jeremy Geffen; Michael T Deavers; Charlotte C Sun; Nora Horick; Herbert Fritsche; Robert C Bast
Journal:  Cancer       Date:  2013-08-26       Impact factor: 6.860

7.  Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses' Health Studies.

Authors:  Megan S Rice; Susan E Hankinson; Shelley S Tworoger
Journal:  Fertil Steril       Date:  2014-05-10       Impact factor: 7.329

8.  Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study.

Authors:  S E Hankinson; D J Hunter; G A Colditz; W C Willett; M J Stampfer; B Rosner; C H Hennekens; F E Speizer
Journal:  JAMA       Date:  1993-12-15       Impact factor: 56.272

Review 9.  Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.

Authors:  Hong-Xia Li; Zhao-Hui Lu; Keng Shen; Wen-Jun Cheng; Anais Malpica; Jing Zhang; Jian-Jun Wei; Zhi-Hong Zhang; Jinsong Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

10.  Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

Authors:  Noah D Kauff; Susan M Domchek; Tara M Friebel; Mark E Robson; Johanna Lee; Judy E Garber; Claudine Isaacs; D Gareth Evans; Henry Lynch; Rosalind A Eeles; Susan L Neuhausen; Mary B Daly; Ellen Matloff; Joanne L Blum; Paul Sabbatini; Richard R Barakat; Clifford Hudis; Larry Norton; Kenneth Offit; Timothy R Rebbeck
Journal:  J Clin Oncol       Date:  2008-02-11       Impact factor: 44.544
View more
  2 in total

Review 1.  Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.

Authors:  Roi Tschernichovsky; Annekathryn Goodman
Journal:  Oncologist       Date:  2017-03-17

2.  "It was a no-brainer": A qualitative study of factors driving previvors' decision-making when considering risk-reducing salpingectomy with delayed oophorectomy.

Authors:  Caroline Gellman; Charlotte Ezratty; Julia Schwarz; Valentin Kolev; Stephanie V Blank
Journal:  Gynecol Oncol Rep       Date:  2022-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.